logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
R

Rita Nanda

university of chicago
H指数:56
被引数:1.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Peripheral blood transcriptional profiling predicts tumor subtype and neoadjuvant chemoimmunotherapy outcomes in human breast cancer

外周血转录组分析预测人乳腺癌的肿瘤亚型及新辅助化免治疗效果

Science Translational Medicine
IF14.6
2026-04-220
PRE
Xiaopeng Sun; Andres A. Ocampo; Ann Hanna; Brandie C. Taylor; Jacey L. Marshall; Julia A. Steele; Margaret L. Axelrod; Elizabeth C. Wescott; Susan R. Opalenik; Angela DeMichele; Laura J. Esserman; Minetta C. Liu; Rita Nanda; Denise M. Wolf; Lamorna Brown Swigart; Gillian L. Hirst; Laura J. van ‘t Veer; Yaomin Xu; Justin M. Balko
Single-Cell Profiling Reveals a Treg-Rich; NK Cell-Depleted Immune Microenvironment in Triple-Negative Breast Cancer with High-Glucocorticoid Receptor Expression

单细胞分析揭示高糖皮质激素受体表达的三阴性乳腺癌中存在Treg富集、NK细胞耗竭的免疫微环境

breast cancer: targets and therapy
IF0
2026-04-140
OAAI
Joshua Behar; Christine Shiang; Deniz Nesli Dolcen; Lynda B Bennett; Andrew W DeVilbiss; Margarite D Matossian; Isaac S Chan; Rita Nanda; Suzanne D Conzen; John T Lafin
Carboplatin, gemcitabine, and mifepristone for advanced breast and recurrent/persistent epithelial ovarian cancer

卡铂、吉西他滨和米非司酮用于晚期乳腺癌和复发性/持续性上皮性卵巢癌

Breast Cancer Research and Treatment
IF3
2025-08-080
OA
Erica M. Stringer-Reasor; Poornima Saha; Masha Kocherginsky; Ricardo Lastra; Gabrielle Baker; Ernst Lenygel; Theodore Karrison; Lauren Olalde; Elizabeth Mokrzycki; Olwen M. Hahn; Philip C. Hoffman; Suzanne D. Conzen; Gini F. Fleming; Rita Nanda
Effectiveness of sacituzumab govitecan and management of neutropenia in patients with metastatic triple-negative breast cancer treated in real-world settings in the United States

曲拉留单抗 govitecan 的有效性及在美国真实世界环境中治疗转移性三阴性乳腺癌患者的中性粒细胞减少症管理

ESMO Open
IF8.3
2025-06-010
OA
R. Nanda; C. Yam; L. Spring; M.A. Bhave; I. Ntalla; T. Valdez; B. Stwalley; C. Liang; W.-H. Wu; N. Sjekloca; N. Sadetsky; C. Lai; K. Kalinsky
Treatment, toxicity, and mortality after subsequent breast cancer in female survivors of childhood cancer

后续乳腺癌治疗、毒性和死亡率：女性儿童癌症幸存者研究

NATURE COMMUNICATIONS
IF15.7
2025-03-311
OA
Im, Cindy; Hasan, Hasibul; Stene, Emily; Monick, Sarah; Rader, Ryan K.; Sheade, Jori; Wolfe, Heather; Lu, Zhanni; Spector, Logan G.; Mcdonald, Aaron J.; Nolan, Vikki; Arnold, Michael A.; Conces, Miriam R.; Moskowitz, Chaya S.; Henderson, Tara O.; Robison, Leslie L.; Armstrong, Gregory T.; Yasui, Yutaka; Nanda, Rita; Oeffinger, Kevin C.; Neglia, Joseph P.; Blaes, Anne; Turcotte, Lucie M.
Efficacy of sacituzumab govitecan versus treatment of physician's choice in previously treated HR+ and HER2-mBC: a meta-analysis of TROPiCS-02 and EVER-132-002 trials

沙西妥昔单抗戈维他宁与医生选择治疗方案在先前治疗过的HR+和HER2-mBC中的疗效：TROPiCS-02和EVER-132-002试验的荟萃分析

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-03-140
OA
Oleg Gluz; Binghe Xu; Rita Nanda; Anandaroop Dasgupta; Ankita Kaushik; Wendy Verret; Akanksha Sharma; Barinder Singh; Hope S. Rugo
A randomized phase II trial of nab-paclitaxel with or without mifepristone for advanced triple-negative breast cancer

nab-紫杉醇联合或不联合米非司酮治疗晚期三阴性乳腺癌的随机II期试验

BREAST CANCER RESEARCH AND TREATMENT
IF3
2025-02-100
OAAI
Chen, Nan; Matossian, Margarite; Saha, Poornima; Rampurwala, Murtuza; Kamaraju, Salaija; Hahn, Olwen; Howard, Frederick M.; Fleming, Gini F.; Freeman, Jincong Q.; Karrison, Theodore; Conzen, Suzanne; Nanda, Rita; Stringer-Reasor, Erica M.
Pathologic complete response (pCR) rates for patients with HRD/HER2L high-risk, early-stage breast cancer (EBC) by clinical and molecular features in the phase II I-SPY2 clinical trial

在I-SPY2临床试验中，根据临床和分子特征，HRD/HER2L高风险早期乳腺癌（EBC）患者的病理完全缓解（pCR）率。

ANNALS OF ONCOLOGY
IF65.4
2025-02-012
PRE
Huppert, L. A.; Wolf, D.; Yau, C.; Brown-Swigart, L.; Hirst, G. L.; Isaacs, C.; Pusztai, L.; Pohlmann, P. R.; Demichele, A.; Shatsky, R.; Yee, D.; Thomas, A.; Nanda, R.; Perlmutter, J.; Heditsian, D.; Hylton, N.; Symmans, F.; van't Veer, L. J.; Esserman, L.; Rugo, H. S.
High tumor glucocorticoid receptor expression in early-stage, triple-negative breast cancer is associated with increased T-regulatory cell infiltration

早期三阴性乳腺癌中肿瘤糖皮质激素受体高表达与调节性T细胞浸润增加有关

BREAST CANCER RESEARCH AND TREATMENT
IF3
2024-11-230
OAAI
Matossian, Margarite D.; Shiang, Christine; Dolcen, Deniz Nesli; Dreyer, Marie; Hatogai, Ken; Hall, Katie; Saha, Poornima; Biernacka, Anna; Sweis, Randy F.; Karrison, Theodore; Chen, Nan; Nanda, Rita; Conzen, Suzanne D.
Multi-platform biomarkers of response to an immune checkpoint inhibitor in the neoadjuvant I-SPY 2 trial for early-stage breast cancer
CELL REPORTS MEDICINE
IF10.6
2024-11-010
OAAI
Campbell, Michael J.; Wolf, Denise M.; Yau, Christina; Brown-Swigart, Lamorna; Wulfkuhle, Julie; Gallagher, Isela R.; Zhu, Zelos; Bolen, Jennifer; Vandenberg, Scott; Hoyt, Clifford; Mori, Hidetoshi; Borowsky, Alexander; Sit, Laura; Perlmutter, Jane; Asare, Smita M.; Nanda, Rita; Liu, Minetta C.; Yee, Douglas; Demichele, Angela M.; Hylton, Nola M.; Pusztai, Lajos; Berry, Donald A.; Hirst, Gillian L.; Petricoin, Emanuel F.; van't Veer, Laura; Esserman, Laura
Regional lymph node changes on breast MRI in patients with early-stage breast cancer receiving neoadjuvant chemo-immunotherapy

接受新辅助化免疫治疗的早期乳腺癌患者乳腺MRI上区域淋巴结的改变

BREAST CANCER RESEARCH AND TREATMENT
IF3
2024-09-210
OAAI
Jacob, Saya; Christofferson, Anika; Fisch, Samantha; Norwood, Peter; Castillo, Paolo; Yu, Hongmei; Hirst, Gillian; Soliman, Hatem; Nanda, Rita; Mukhtar, Rita A.; Ewing, Cheryl; Majure, Melanie; Melisko, Michelle; Rugo, Hope S.; Esserman, Laura; Price, Elissa; Chien, A. Jo
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Datopotamab-deruxtecan治疗早期乳腺癌: 序贯多重分配随机I-SPY2.2 2期试验

NATURE MEDICINE
IF50
2024-09-141
PRE
Khoury, Katia; Meisel, Jane L.; Yau, Christina; Rugo, Hope S.; Nanda, Rita; Davidian, Marie; Tsiatis, Butch; Chien, A. Jo; Wallace, Anne M.; Arora, Mili; Rozenblit, Mariya; Hershman, Dawn L.; Zimmer, Alexandra; Clark, Amy S.; Beckwith, Heather; Elias, Anthony D.; Stringer-Reasor, Erica; Boughey, Judy C.; Nangia, Chaitali; Vaklavas, Christos; Omene, Coral; Albain, Kathy S.; Kalinsky, Kevin M.; Isaacs, Claudine; Tseng, Jennifer; Torres, Evanthia T. Roussos; Thomas, Brittani; Thomas, Alexandra; Sanford, Amy; Balassanian, Ronald; Ewing, Cheryl; Yeung, Kay; Sauder, Candice; Sanft, Tara; Pusztai, Lajos; Trivedi, Meghna S.; Outhaythip, Ashton; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Beedle, Carolyn; Perlmutter, Jane; Pohlmann, Paula; Shatsky, Rebecca A.; Demichele, Angela; Yee, Douglas; van't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Datopotamab-deruxtecan联合durvalumab治疗早期乳腺癌: 序贯多重分配随机I-SPY2.2 2期试验

NATURE MEDICINE
IF50
2024-09-144
PRE
Shatsky, Rebecca A.; Trivedi, Meghna S.; Yau, Christina; Nanda, Rita; Rugo, Hope S.; Davidian, Marie; Tsiatis, Butch; Wallace, Anne M.; Chien, A. Jo; Stringer-Reasor, Erica; Boughey, Judy C.; Omene, Coral; Rozenblit, Mariya; Kalinsky, Kevin; Elias, Anthony D.; Vaklavas, Christos; Beckwith, Heather; Williams, Nicole; Arora, Mili; Nangia, Chaitali; Torres, Evanthia T. Roussos; Thomas, Brittani; Albain, Kathy S.; Clark, Amy S.; Falkson, Carla; Hershman, Dawn L.; Isaacs, Claudine; Thomas, Alexandra; Tseng, Jennifer; Sanford, Amy; Yeung, Kay; Boles, Sarah; Chen, Yunni Yi; Huppert, Laura; Jahan, Nusrat; Parker, Catherine; Giridhar, Karthik; Howard, Frederick M.; Blackwood, M. Michele; Sanft, Tara; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Heditsian, Diane; Lestage, Barbara; Perlmutter, Jane; Pohlmann, Paula; Demichele, Angela; Yee, Douglas; van 't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.

研究方向

暂未获取到该数据
C
Claudine Isaacs
H 指数:97论文数:751被引数:3.7万
H
Hope S. Rugo
H 指数:137论文数:1,616被引数:10.0万
C
Christina Yau
H 指数:92论文数:571被引数:7.9万
A
Angela DeMichele
H 指数:89论文数:736被引数:2.8万
D
Douglas Yee
H 指数:83论文数:583被引数:2.5万
L
Laura J. Esserman
H 指数:89论文数:990被引数:3.3万
F
Frederick M. Howard
H 指数:20论文数:126被引数:2,707
K
Kathy S. Albain
H 指数:88论文数:504被引数:4.2万
O
Olufunmilayo I. Olopade
H 指数:108论文数:1,106被引数:4.6万
J
Judy C. Boughey
H 指数:80论文数:838被引数:2.3万